Biden administration releases prices of 10 drugs in Medicare negotiations, says U.S. will save $6 billion in first year
It is a milestone in a controversial process that aims to make costly medications more affordable for older Americans but is strongly opposed by drugmakers.
It is a milestone in a controversial process that aims to make costly medications more affordable for older Americans but is strongly opposed by drugmakers.
